California Public Employees Retirement System’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-80,144
Closed -$7.77M 3452
2019
Q3
$7.77M Buy
80,144
+19,362
+32% +$1.94M 0.01% 992
2019
Q2
$6.22M Buy
60,782
+400
+0.7% +$43.2K 0.01% 997
2019
Q1
$6.88M Buy
60,382
+10,482
+21% +$770K 0.01% 988
2018
Q4
$1.95M Buy
49,900
+12,000
+32% +$520K ﹤0.01% 1736
2018
Q3
$2.07M Sell
37,900
-2,900
-7% -$198K ﹤0.01% 1886
2018
Q2
$3.38M Buy
40,800
+1,300
+3% +$100K ﹤0.01% 1554
2018
Q1
$2.63M Sell
39,500
-1,900
-5% -$110K ﹤0.01% 1735
2017
Q4
$2.13M Buy
41,400
+1,600
+4% +$115K ﹤0.01% 1909
2017
Q3
$3.55M Buy
39,800
+700
+2% +$53.1K 0.01% 1546
2017
Q2
$2.34M Buy
39,100
+800
+2% +$44.7K ﹤0.01% 1766
2017
Q1
$2.04M Sell
38,300
-1,700
-4% -$101K ﹤0.01% 1869
2016
Q4
$2M Hold
40,000
﹤0.01% 1902
2016
Q3
$2.4M Buy
+40,000
New +$2.31M ﹤0.01% 1809

California Public Employees Retirement System's ONCE Position: Q4 2019 in Review

California Public Employees Retirement System sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 80,144 shares — an estimated $7.77M sold.

California Public Employees Retirement System first reported a position in ONCE in Q3 2016 and held it in 13 quarters. The position peaked at $7.77M in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • California Public Employees Retirement System reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • California Public Employees Retirement System sold 80,144 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $7.77M.
  • California Public Employees Retirement System first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2016 and held it in 13 quarters.
  • California Public Employees Retirement System's Spark Therapeutics, Inc. Common Stock position peaked at $7.77M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on California Public Employees Retirement System's 13F filing for Q4 2019, filed 27 Jan 2020.